The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Dermatology Drug-Global Market Insights and Sales Trends 2025
Synopsis
Dermatology Drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases.
The global Dermatology Drug market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Dermatology Drug in various end use industries. The expanding demands from the Psoriasis, Skin Infections, Acne and Dermatitis, are propelling Dermatology Drug market. External Use, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Oral segment is estimated at % CAGR for the next seven-year period.
In the US market, the major manufacturers are AbbVie, Johnson & Johnson, Bayer, Galderma, Bristol-Myers Squibb, Novartis, Pfizer, Merz Pharma, Valeant and Leo Pharma.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Dermatology Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Dermatology Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Dermatology Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Dermatology Drug sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Dermatology Drug covered in this report include AbbVie, Johnson & Johnson, Bayer, Galderma, Bristol-Myers Squibb, Novartis, Pfizer, Merz Pharma and Valeant, etc.
The global Dermatology Drug market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AbbVie
Johnson & Johnson
Bayer
Galderma
Bristol-Myers Squibb
Novartis
Pfizer
Merz Pharma
Valeant
LEO Pharma
GlaxoSmithKline
Global Dermatology Drug market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Dermatology Drug market, Segment by Type:
External Use
Oral
Injection
Global Dermatology Drug market, by Application
Psoriasis
Skin Infections
Acne
Dermatitis
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Dermatology Drug companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Dermatology Drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases.
The global Dermatology Drug market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Dermatology Drug in various end use industries. The expanding demands from the Psoriasis, Skin Infections, Acne and Dermatitis, are propelling Dermatology Drug market. External Use, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Oral segment is estimated at % CAGR for the next seven-year period.
In the US market, the major manufacturers are AbbVie, Johnson & Johnson, Bayer, Galderma, Bristol-Myers Squibb, Novartis, Pfizer, Merz Pharma, Valeant and Leo Pharma.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Dermatology Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Dermatology Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Dermatology Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Dermatology Drug sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Dermatology Drug covered in this report include AbbVie, Johnson & Johnson, Bayer, Galderma, Bristol-Myers Squibb, Novartis, Pfizer, Merz Pharma and Valeant, etc.
The global Dermatology Drug market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AbbVie
Johnson & Johnson
Bayer
Galderma
Bristol-Myers Squibb
Novartis
Pfizer
Merz Pharma
Valeant
LEO Pharma
GlaxoSmithKline
Global Dermatology Drug market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Dermatology Drug market, Segment by Type:
External Use
Oral
Injection
Global Dermatology Drug market, by Application
Psoriasis
Skin Infections
Acne
Dermatitis
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Dermatology Drug companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Dermatology Drug
1.1 Dermatology Drug Market Overview
1.1.1 Dermatology Drug Product Scope
1.1.2 Dermatology Drug Market Status and Outlook
1.2 Global Dermatology Drug Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Dermatology Drug Market Size by Region (2018-2029)
1.4 Global Dermatology Drug Historic Market Size by Region (2018-2023)
1.5 Global Dermatology Drug Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Dermatology Drug Market Size (2018-2029)
1.6.1 North America Dermatology Drug Market Size (2018-2029)
1.6.2 Europe Dermatology Drug Market Size (2018-2029)
1.6.3 Asia-Pacific Dermatology Drug Market Size (2018-2029)
1.6.4 Latin America Dermatology Drug Market Size (2018-2029)
1.6.5 Middle East & Africa Dermatology Drug Market Size (2018-2029)
2 Dermatology Drug Market by Type
2.1 Introduction
2.1.1 External Use
2.1.2 Oral
2.1.3 Injection
2.2 Global Dermatology Drug Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Dermatology Drug Historic Market Size by Type (2018-2023)
2.2.2 Global Dermatology Drug Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Dermatology Drug Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Dermatology Drug Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Dermatology Drug Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Dermatology Drug Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Dermatology Drug Revenue Breakdown by Type (2018-2029)
3 Dermatology Drug Market Overview by Application
3.1 Introduction
3.1.1 Psoriasis
3.1.2 Skin Infections
3.1.3 Acne
3.1.4 Dermatitis
3.1.5 Others
3.2 Global Dermatology Drug Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Dermatology Drug Historic Market Size by Application (2018-2023)
3.2.2 Global Dermatology Drug Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Dermatology Drug Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Dermatology Drug Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Dermatology Drug Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Dermatology Drug Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Dermatology Drug Revenue Breakdown by Application (2018-2029)
4 Dermatology Drug Competition Analysis by Players
4.1 Global Dermatology Drug Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dermatology Drug as of 2022)
4.3 Date of Key Players Enter into Dermatology Drug Market
4.4 Global Top Players Dermatology Drug Headquarters and Area Served
4.5 Key Players Dermatology Drug Product Solution and Service
4.6 Competitive Status
4.6.1 Dermatology Drug Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 AbbVie
5.1.1 AbbVie Profile
5.1.2 AbbVie Main Business
5.1.3 AbbVie Dermatology Drug Products, Services and Solutions
5.1.4 AbbVie Dermatology Drug Revenue (US$ Million) & (2018-2023)
5.1.5 AbbVie Recent Developments
5.2 Johnson & Johnson
5.2.1 Johnson & Johnson Profile
5.2.2 Johnson & Johnson Main Business
5.2.3 Johnson & Johnson Dermatology Drug Products, Services and Solutions
5.2.4 Johnson & Johnson Dermatology Drug Revenue (US$ Million) & (2018-2023)
5.2.5 Johnson & Johnson Recent Developments
5.3 Bayer
5.3.1 Bayer Profile
5.3.2 Bayer Main Business
5.3.3 Bayer Dermatology Drug Products, Services and Solutions
5.3.4 Bayer Dermatology Drug Revenue (US$ Million) & (2018-2023)
5.3.5 Galderma Recent Developments
5.4 Galderma
5.4.1 Galderma Profile
5.4.2 Galderma Main Business
5.4.3 Galderma Dermatology Drug Products, Services and Solutions
5.4.4 Galderma Dermatology Drug Revenue (US$ Million) & (2018-2023)
5.4.5 Galderma Recent Developments
5.5 Bristol-Myers Squibb
5.5.1 Bristol-Myers Squibb Profile
5.5.2 Bristol-Myers Squibb Main Business
5.5.3 Bristol-Myers Squibb Dermatology Drug Products, Services and Solutions
5.5.4 Bristol-Myers Squibb Dermatology Drug Revenue (US$ Million) & (2018-2023)
5.5.5 Bristol-Myers Squibb Recent Developments
5.6 Novartis
5.6.1 Novartis Profile
5.6.2 Novartis Main Business
5.6.3 Novartis Dermatology Drug Products, Services and Solutions
5.6.4 Novartis Dermatology Drug Revenue (US$ Million) & (2018-2023)
5.6.5 Novartis Recent Developments
5.7 Pfizer
5.7.1 Pfizer Profile
5.7.2 Pfizer Main Business
5.7.3 Pfizer Dermatology Drug Products, Services and Solutions
5.7.4 Pfizer Dermatology Drug Revenue (US$ Million) & (2018-2023)
5.7.5 Pfizer Recent Developments
5.8 Merz Pharma
5.8.1 Merz Pharma Profile
5.8.2 Merz Pharma Main Business
5.8.3 Merz Pharma Dermatology Drug Products, Services and Solutions
5.8.4 Merz Pharma Dermatology Drug Revenue (US$ Million) & (2018-2023)
5.8.5 Merz Pharma Recent Developments
5.9 Valeant
5.9.1 Valeant Profile
5.9.2 Valeant Main Business
5.9.3 Valeant Dermatology Drug Products, Services and Solutions
5.9.4 Valeant Dermatology Drug Revenue (US$ Million) & (2018-2023)
5.9.5 Valeant Recent Developments
5.10 LEO Pharma
5.10.1 LEO Pharma Profile
5.10.2 LEO Pharma Main Business
5.10.3 LEO Pharma Dermatology Drug Products, Services and Solutions
5.10.4 LEO Pharma Dermatology Drug Revenue (US$ Million) & (2018-2023)
5.10.5 LEO Pharma Recent Developments
5.11 GlaxoSmithKline
5.11.1 GlaxoSmithKline Profile
5.11.2 GlaxoSmithKline Main Business
5.11.3 GlaxoSmithKline Dermatology Drug Products, Services and Solutions
5.11.4 GlaxoSmithKline Dermatology Drug Revenue (US$ Million) & (2018-2023)
5.11.5 GlaxoSmithKline Recent Developments
6 North America
6.1 North America Dermatology Drug Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Dermatology Drug Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Dermatology Drug Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Dermatology Drug Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Dermatology Drug Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Dermatology Drug Market Dynamics
11.1 Dermatology Drug Industry Trends
11.2 Dermatology Drug Market Drivers
11.3 Dermatology Drug Market Challenges
11.4 Dermatology Drug Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
